BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2016
View Archived Issues
Veliparib does not demonstrate clinically significant QTc prolongation in phase I trial
Read More
Atrin Pharmaceuticals wins NCI contract to develop ATR inhibitors
Read More
SOBI-003 granted European orphan drug status
Read More
New Canadian-African trial to study Ebola vaccine VSV-EBOV in subjects with HIV
Read More
Redx nominates new drug development candidate from reversible BTK inhibitor program
Read More
Glucox Biotech discloses Nox4 inhibitors
Read More
CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody
Read More
Novel DNA vaccines against Zika virus infection enter phase I study
Read More
Ionis Pharmaceuticals presents promising clinical data for IONIS-APO(a)Rx and IONIS-APO(a)-LRx
Read More
NBE Therapeutics and SOTIO to develop next-generation ADCs
Read More
FDA grants rare pediatric disease designation to Kuros Biosciences' KUR-112
Read More
Institute of Materia Medica of Beijing patents deoxytylophorinine derivatives
Read More
Merck & Co. describes novel azacarbazole derivatives
Read More
Bristol-Myers Squibb identifies new AP2-associated protein kinase 1 inhibitors
Read More
Araxes Pharma presents novel KRAS Gly12Cys mutant inhibitors
Read More
Enanta Pharmaceuticals divulges anti-hepatitis B virus agents
Read More
Twice daily DA-5204 equal to thrice daily Stillen for treating gastritis
Read More
Advaxis begins part B of KEYNOTE-046 trial
Read More
ProMetic Life Sciences reports results from phase II study of PBI-4050
Read More
EMA awards priority medicine designation to CymaBay Therapeutics' MBX-8025
Read More
NIH grant to support study of Capricor Therapeutics' CAP-2003
Read More
HedgePath Pharmaceuticals provides interim data from phase IIb study of SUBA-Itraconazole
Read More
Debiopharm enters clinical collaboration with Merck KGaA and Pfizer
Read More
Karolinska Development company Dilaforette to change name to Modus Therapeutics
Read More
Positive topline results from FORWARD-5 pivotal phase III study of ALKS-5461 in patients with MDD
Read More
FIT phase III trials and open-label extension study show consistent benefit of fostamatinib
Read More
High rate of response seen with dabrafenib in pediatric low-grade gliomas
Read More
Johnson & Johnson offers overview of third quarter 2016
Read More